Join Our Cocaine Trial

Catalyst Pharmaceutical Partners, in collaboration with the National Institute on Drug Abuse and the U.S. Department of Veterans Affairs Cooperative Studies Program, is conducting a study to learn more about the effectiveness and safety as a treatment for cocaine dependence of vigabatrin (vi•gá•ba•trin, des­ig­nated CPP-109 by Catalyst), which is approved in the U.S. and other countries for other uses. For technical information about this study, please see clinicaltrials.gov, a service of the U.S. National Institutes of Health.

Interested?

For further information about our cocaine trial, please see www.cocainetreatmentstudy.com. At this site you can find answers to general questions about clinical trials. And if you're considering taking part in our clinical trial, answers to frequently asked questions will help you understand the study and your possible role in it. Complete the online questionnaire to find out if you qualify to be evaluated further by a site near you.

To participate in our cocaine trial, please either

  • Complete the online questionnaire or
  • Call 1-877-309-2958 (toll-free) to speak with a nurse who can answer your questions and tell you if you qualify for further screening.

Any information you provide will be kept strictly confidential.

Do you qualify?

You may qualify to participate in our cocaine trial if you:

  • Are at least 18 years of age (male or female).
  • Are addicted to cocaine and are seeking to stop cocaine use.
  • Are able and willing to follow the instructions given by site staff, including taking the study drug as instructed, going to all study visits (or calling to reschedule), complying with drug testing, and completing all assessments.
  • Do not have high blood pressure or eye disease.
  • Are not in a treatment program (other than a self-help program such as Alcoholics Anonymous, Narcotics Anonymous, or Cocaine Anonymous).
  • Not pregnant or breast feeding or plan to be while in the study.